Prostatype Genomics AB (SE0023261532) — research page
SE · se-cm-kg/SSME/SE0023261532 · as of 2026-11-06
Identity and listing
Prostatype Genomics AB is listed on First North Sweden under ticker SE0023261532, ISIN SE0023261532 and LEI 549300JO6MPCGPVHVU91. The record does not hold its security type, segment, sector or jurisdiction. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Prostatype Genomics AB | source · 2026-11-06 |
| exchange | First North Sweden | source · 2026-11-06 |
| ticker | SE0023261532 | source · 2026-11-06 |
| ISIN | SE0023261532 | source · 2026-11-06 |
| LEI | 549300JO6MPCGPVHVU91 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 28 filings across 25 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 7.0 days, against a First North Sweden median of 11.0 days across 325 issuers. The latest filing is dated 2026-10-09 and is of type Other information disclosed according to the rules of the Exchange, 28 days before the record date of 2026-11-06. The latency median for First North Sweden is 7 days. The record does not hold a sector median for this market.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 28 | 7 | 28 |
| exchange median: First North Sweden (325 issuers) | 21 | 11 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-09 | Other information disclosed according to the rules of the Exchange | Other information disclosed according to the rules of the Exchange | Prostatype Genomics has submitted additional responses in the Medicare review process - working meeting planned for November |
| 2026-10-05 | Company Announcement | Company Announcement | Interview with the CEO of Prostatype Genomics |
| 2026-09-30 | Corporate Action | Corporate Action | New, strong data for Prostatype® presented at a scientific congress |
| 2026-09-23 | Corporate Action | Corporate Action | Prostatype Genomics provides update on the Medicare process regarding Prostatype® |
| 2026-09-21 | Other information disclosed according to the rules of the Exchange | Other information disclosed according to the rules of the Exchange | New shares from exercise of warrants of series TO6 registered with the Swedish Companies Registration Office |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The record does not hold the auditor of record, its location, or any auditor changes.
Events and halts
The record does not hold listing, delisting, name change, domicile change or segment move events, because the lifecycle type map for this register is not yet in place. The halt flag is not set: the issuer is listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories for this market. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 2 research houses: Aktiespararna and Redeye.
| research house | analyst | source · read date |
|---|---|---|
| Aktiespararna | issuer page · 2026-11-12 | |
| Redeye | issuer page · 2026-11-12 |
Open research
The record holds 1 openly published research note, by Aktiespararna, dated 2024-05-01.
| date | publisher | note | kind |
|---|---|---|---|
| 2024-05-01 | Aktiespararna | Reinitieringsanalys Prostatype Genomics | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. The record holds no sealed years for this issuer, no earliest sealed date for the market, and no live-record start date.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/SSME/SE0023261532 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://www.prostatypegenomics.com/investor-relations/analyst-coverage/ (coverage)
- 10.7
- https://storage.mfn.se/b311ab7d-a498-4824-9986-9a365e9226f9/reinitieringsanalys-prostatype-genomics-maj-2024.pdf (open research)
- 10.8
- https://mcp.se-cm-kg.ai/record/SSME/SE0023261532 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0023261532"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:3445811b672236ad.